Ximelagatran/Melagatran: A Review of its Use in the Prevention of Venous Thromboembolism in Orthopaedic Surgery

By Evans H.C.   Perry C.M.   Faulds D.  

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 649-678

Adis International

Access to resources Recommend Favorite

Direct Thrombin Inhibitors for the Prevention of Venous Thromboembolism after Major Orthopaedic Surgery

By  

Current Pharmaceutical Design, Vol. 11, Iss. 30, 2005-11 ,pp. : 3885-3891

Bentham Science Publishers

Access to resources Recommend Favorite

Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery: Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety

By Ola E. Dahl  

Clinical Drug Investigation, Vol. 25, Iss. 1, 2005-01 ,pp. : 65-77

Adis International

Access to resources Recommend Favorite

Dabigatran Etexilate: A Review of its Use for the Prevention of Venous Thromboembolism after Total Hip or Knee Replacement Surgery

By Burness Celeste B.   McKeage Kate  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 963-986

Adis International

Access to resources Recommend Favorite

Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery: A NICE Single Technology Appraisal

By Holmes Michael   Carroll Christopher   Papaioannou Diana  

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 137-146

Adis International

Access to resources Recommend Favorite